Lebanon National Drugs Database

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

...

195

All

ATC	Name	B/G	Ingredients	Form	Price
R03AK06	SEROFLO-S 125	G	Salmeterol (xinafoate) - 25mcg/inhalation, Fluticasone propionate - 125mcg/inhalation	Inhalation suspension	1,212,146 L.L
A02AC10	RENNIE	B	Magnesium carbonate - 80mg, Calcium carbonate - 680mg	Tablet, chewable	240,548 L.L
A10BD15	ZYGLOMET XR 10/1000	G	Dapagliflozin - 10mg, Metformin HCl XR - 1000mg	Tablet, film coated	2,467,295 L.L
B05BB02	DEXTROSE 2.5% & SODIUM CHLORIDE 0.45%	G	Sodium chloride - 0.45g/100ml, Dextrose, H2O - 2.5g/100ml	Injectable solution	212,598 L.L
C09DX03	VOCADO HCT	B	Olmesartan medoxomil - 40mg, Amlodipine - 10mg, Hydrochlorothiazide - 25mg	Tablet, film coated	1,523,917 L.L
D06AX	BATRAMYCIN	B	Neomycin (sulfate) - 5000IU/g, Bacitracin - 250IU/g	Ointment	249,955 L.L
R03AK06	CYVAX	G	Salmeterol (xinafoate) - 25mcg/inhalation, Fluticasone propionate - 250mcg/inhalation	Inhalation suspension	1,710,712 L.L
A02AC10	TUMS EXTRA STRENGTH 750 ASSORTED FRUIT	B	Calcium carbonate - 750mg	Tablet, chewable	421,967 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 10mg	Tablet, film coated	4,482,387 L.L
B05BB02	DEXTROSE 2.5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 2.5%	Injectable solution	185,018 L.L
C09DX03	OLMENOR TRIPLE	G	Olmesartan medoxomil - 40mg, Amlodipine (besylate) - 10mg, Hydrochlorothiazide - 25mg	Tablet, film coated	1,067,011 L.L
D06AX	DERMOTRACIN	G	Neomycin sulfate - 165.000IU/150ml, Bacitracin - 15.500IU/150ml	Powder	737,770 L.L
R03AK06	SEROFLO 250	G	Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 250mcg/inhalation	Inhalation suspension	1,580,359 L.L
A02AF02	MAALOX PLUS	B	Dimethicone - 25mg, Aluminium hydroxide - 200mg, Magnesium hydroxide - 200mg	Tablet, chewable	166,636 L.L
A06AB05	HUILE DE RICIN	G	Castor oil -	Liquid	163,821 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 10mg	Tablet, film coated	4,482,387 L.L
B05BB02	DEXTROSE 2.5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 2.5%	Injectable solution	174,675 L.L
C09DX03	VOCADO HCT	B	Olmesartan medoxomil - 40mg, Amlodipine - 10mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	1,523,917 L.L
D06AX	TRIPLE ANTIBIOTIC ORIGINAL OINTMENT		Bacitracin - 400U, Neomycin (sulfate) - 3.5mg, Polymyxin B (sulfate) - 5000U		580,540 L.L
R03AK06	SEROFLO-S 250	G	Salmeterol (xinafoate) - 25mcg/inhalation, Fluticasone propionate - 250mcg/inhalation	Inhalation suspension	1,725,494 L.L
A02AF02	ACTONORM	B	Aluminium hydroxide - 220mg/5ml, Magnesium hydroxide - 200mg/5ml, Simethicone - 25mg/5ml	Suspension	403,153 L.L
A06AB07	COLON-X	G	Frangula Purshiana - 62.5mg, Plantago Afra - 100mg, Foeniculum Vulgare - 50mg, Zingiber Officinale - 50mg, Aniseed powder - 20mg, Glycyrrhiza Glabra - 12.5mg, Senna Alexandrina - 25mg	Tablet, film coated	833,182 L.L
A10BD19	EMPAGLINE	G	Empagliflozin - 10mg, Linagliptin - 5mg	Tablet, film coated	2,237,050 L.L
B05BB02	DEXTROSE 2.5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 2.5%	Injectable solution	148,566 L.L
C09DX03	OLMENOR TRIPLE	G	Olmesartan medoxomil - 40mg, Amlodipine (besylate) - 10mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	1,067,011 L.L
R03AK07	SYMBICORT	B	Formoterol fumarate dihydrate - 4.5mcg/Inhalation, Budesonide - 160mcg/Inhalation	Inhalation powder	3,378,420 L.L
A02AF02	MAALOX PLUS	B	Simethicone - 25mg/5ml, Aluminium hydroxide - 175mg/5ml, Magnesium hydroxide - 200mg/5ml	Suspension	438,093 L.L
A06AB58	PICOPREP	B	Magnesium oxide - 3.5g, Citric acid - 12g, Sodium picosulfate - 10mg	Powder	694,767 L.L
A10BD19	EMPALYN	G	Empagliflozin - 10mg, Linagliptin - 5mg	Tablet, film coated	2,237,050 L.L
B05BB02	SOLUFLEX DEXTROSE 2.5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 2.5%	Injectable solution	150,543 L.L

...

195